Latest Insider Transactions at Biomarin Pharmaceutical Inc (BMRN)
This section provides a real-time view of insider transactions for Biomarin Pharmaceutical Inc (BMRN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOMARIN PHARMACEUTICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOMARIN PHARMACEUTICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.33%
|
$37,000
$37.46 P/Share
|
|
May 25
2021
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+26.9%
|
-
|
|
May 25
2021
|
Willard H Dere Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+21.76%
|
-
|
|
May 25
2021
|
Elaine J Heron Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+6.63%
|
-
|
|
May 25
2021
|
Maykin Ho Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+40.67%
|
-
|
|
May 25
2021
|
Robert J. Hombach Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+19.36%
|
-
|
|
May 25
2021
|
V Bryan Lawlis Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+17.6%
|
-
|
|
May 25
2021
|
Richard A Meier Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+4.9%
|
-
|
|
May 25
2021
|
David E I Pyott Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+12.49%
|
-
|
|
May 25
2021
|
Dennis Slamon Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,120
+15.44%
|
-
|
|
May 10
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
8,513
-2.73%
|
$655,501
$77.29 P/Share
|
|
May 10
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,513
+2.65%
|
$221,338
$26.49 P/Share
|
|
May 07
2021
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,709
-17.62%
|
$530,011
$79.5 P/Share
|
|
May 07
2021
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,709
+14.98%
|
$187,852
$28.23 P/Share
|
|
May 07
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
25,000
-2.59%
|
$1,950,000
$78.59 P/Share
|
|
May 07
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.07%
|
$650,000
$26.49 P/Share
|
|
May 06
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
25,000
-3.87%
|
$1,950,000
$78.35 P/Share
|
|
May 06
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.07%
|
$650,000
$26.49 P/Share
|
|
May 06
2021
|
Richard A Meier Director |
SELL
Open market or private sale
|
Direct |
5,068
-5.1%
|
$395,304
$78.38 P/Share
|
|
May 06
2021
|
Richard A Meier Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+13.12%
|
$390,000
$26.49 P/Share
|
|
May 04
2021
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,986
-8.73%
|
$310,908
$78.35 P/Share
|
|
May 03
2021
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,673
-3.46%
|
$364,494
$78.3 P/Share
|
|
Apr 30
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
342
+0.58%
|
$21,204
$62.41 P/Share
|
|
Apr 30
2021
|
Andrea Acosta GVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
271
+1.45%
|
$16,802
$62.41 P/Share
|
|
Apr 30
2021
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
341
+1.08%
|
$21,142
$62.41 P/Share
|
|
Apr 30
2021
|
Jean Jacques Bienaime Director |
BUY
Grant, award, or other acquisition
|
Direct |
341
+0.11%
|
$21,142
$62.41 P/Share
|
|
Apr 30
2021
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
221
+0.48%
|
$13,702
$62.41 P/Share
|
|
Apr 30
2021
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
341
+0.49%
|
$21,142
$62.41 P/Share
|
|
Apr 30
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.33%
|
$37,000
$37.46 P/Share
|
|
Apr 23
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.2%
|
$790,000
$79.34 P/Share
|
|
Apr 23
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.1%
|
$260,000
$26.49 P/Share
|
|
Apr 22
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.2%
|
$780,000
$78.91 P/Share
|
|
Apr 22
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.1%
|
$260,000
$26.49 P/Share
|
|
Apr 19
2021
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,709
-3.81%
|
$214,011
$79.58 P/Share
|
|
Apr 19
2021
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,709
+3.67%
|
$70,434
$26.49 P/Share
|
|
Apr 15
2021
|
V Bryan Lawlis Director |
SELL
Open market or private sale
|
Direct |
7,500
-28.46%
|
$570,000
$76.9 P/Share
|
|
Apr 15
2021
|
V Bryan Lawlis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+22.16%
|
$195,000
$26.49 P/Share
|
|
Apr 08
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,537
-2.57%
|
$119,886
$78.81 P/Share
|
|
Apr 01
2021
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,692
-15.51%
|
$432,592
$76.3 P/Share
|
|
Mar 30
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,652
-2.69%
|
$122,248
$74.79 P/Share
|
|
Mar 24
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,181
-1.89%
|
$89,756
$76.3 P/Share
|
|
Mar 22
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-2.36%
|
$118,014
$78.52 P/Share
|
|
Mar 22
2021
|
Jean Jacques Bienaime Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,519
-1.79%
|
$430,482
$78.52 P/Share
|
|
Mar 22
2021
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,391
-1.99%
|
$108,498
$78.52 P/Share
|
|
Mar 22
2021
|
Henry J Fuchs President, Worldwide R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,454
-2.26%
|
$191,412
$78.52 P/Share
|
|
Mar 22
2021
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
516
-1.39%
|
$40,248
$78.52 P/Share
|
|
Mar 18
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,308
-2.0%
|
$100,716
$77.99 P/Share
|
|
Mar 16
2021
|
Andrea Acosta GVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
379
-2.05%
|
$29,183
$77.21 P/Share
|
|
Mar 16
2021
|
Jean Jacques Bienaime Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,559
-1.77%
|
$428,043
$77.21 P/Share
|
|
Mar 16
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,287
-1.93%
|
$99,099
$77.21 P/Share
|